HB 1154 Louisiana House · 2026 Regular Session

INSURANCE: Prohibits prior authorizations requirements for certain generic medications prescribed by qualified physicians (EN NO IMPACT GF EX See Note)

This bill prohibits health insurance companies and Medicaid managed care organizations from requiring prior authorization for certain generic medications when prescribed by board-certified physicians. The law defines a board-certified physician as a doctor certified by a recognized medical specialty board and a generic medication as a drug chemically equivalent to a brand-name drug approved by the FDA. Under this legislation, insurers must cover these specific generic prescriptions without needing additional approval from the insurance company before dispensing or reimbursing them. The restrictions apply to new insurance policies and contracts starting January 1, 2027, with existing plans required to comply by January 1, 2028.
Bill status signed all 5 stages cleared
Introduction
Mar 2026
Committee Review
May 2026
House Passage
May 2026
Senate Passage
May 2026
Signed into Law
Jun 2026
Introduced Mar 31, 2026 Signed Jun 2, 2026
Maddy AI version diff · 5 comparisons

What changed between versions

HB1154 Original HB1154 Act 706 · 9 edits
MAJOR
The bill was expanded from a single sponsor to a group of representatives and updated its official title to reflect that it now applies to both physicians and authorized providers. The core policy remains the same: prohibiting insurance companies from requiring prior authorization for certain generic medications prescribed by qualified professionals. The bill also clarifies that these medications must not be opioids and must cost no more than $250 per prescription.
Scope change
The bill's scope was broadened to include 'authorized providers' in addition to 'board-certified physicians' as eligible prescribers for the prior authorization exemption.
ELIGIBILITY

Added 'authorized providers' to the list of qualified prescribers eligible for the prior authorization exemption, alongside board-certified physicians.

TECHNICAL

Updated the sponsor list from a single representative to a group of representatives and refined the bill's short title.

DEFINITION

Added the term 'authorized provider' to the list of defined terms in the statute.

Removed the definition of 'commercial insurer' from the text as it appears to be redundant or handled elsewhere.

Removed the definition of 'Medicaid managed care organization' from the text.

Removed the definition of 'health coverage plan' from the text.

Removed the definition of 'Medicaid managed care contract' from the text.

REQUIREMENT

Added a specific requirement that the generic medication must not be an opioid to qualify for the exemption.

Added a cost threshold requiring the wholesale acquisition cost of the medication to be no more than $250 per prescription.

Floor votes · Senate May 25, 2026 · House May 5, 2026

How they voted

390
Passed · 1 other
Total votes 40
May 25, 2026
D Democratic12
11 Yea 1
91% Yea
R Republican28
28 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
20
Key actions
5
Committee
6
May 25, 2026
Upper · Passed
Rules suspended. Read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
May 14, 2026
Committee
Read by title and referred to the Legislative Bureau.
upper
May 13, 2026
Upper · Passed
Reported favorably.
upper
May 5, 2026
Lower · Passed
Read third time by title, amended, roll called on final passage, yeas 101, nays 0. Finally passed, title adopted, ordered to the Senate.
lower
Apr 27, 2026
Lower · Passed
Reported with amendments (13-0).
lower
Apr 16, 2026
Committee
Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations.
lower
Apr 15, 2026
Lower · Passed
Reported with amendments (13-0).
lower
Apr 1, 2026
Committee
Read by title, under the rules, referred to the Committee on Insurance.
lower
1 primary · 13 co-sponsors

Sponsors